Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
SEC Accession No. 0001213900-25-098805
Filing Date
2025-10-14
Accepted
2025-10-14 16:44:01
Documents
3

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 1 TO FORM S-3 ea026112602-s3a1_oruka.htm S-3/A 286918
2 CONSENT OF PRICEWATERHOUSECOOPERS LLP, INDEPENDENT REGISTERED PUBLIC ACCOUNTING ea026112602ex23-1_oruka.htm EX-23.1 1932
3 GRAPHIC image_001.jpg GRAPHIC 12309
  Complete submission text file 0001213900-25-098805.txt   307242
Mailing Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025
Business Address 855 OAK GROVE AVE. SUITE 100 MENLO PARK CA 94025 650-606-7910
Oruka Therapeutics, Inc. (Filer) CIK: 0000907654 (see all company filings)

EIN.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-3/A | Act: 33 | File No.: 333-290715 | Film No.: 251392314
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)